Figure 4
From: Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy
The ratio of each parameter value at Day14, Day28 and Day70 over its value at baseline (Day0) for both ROI type I and ROI type II, segregated for progressors and non-progressors. The parameters with statistically significantly different between the two cohorts are identified (*p < 0.5, **p < 0.01).
